Works by Avila, Robin L.

Results: 17

Constitutively Active Akt Induces Enhanced Myelination in the CNS.

Published in:

Journal of Neuroscience, 2008, v. 28, n. 28, p. 7174, doi. 10.1523/JNEUROSCI.0150-08.2008

By:

Flores, Ana I.;
Narayanan, S. Priyadarshini;
Morse, Emily N.;
Shick, H. Elizabeth;
Xinghua Yin;
Kidd, Grahame;
Avila, Robin L.;
Kirschner, Daniel A.;
Macklin, Wendy B.

Publication type:

Article

Different Intracellular Pathomechanisms Produce Diverse Myelin Protein Zero Neuropathies in Transgenic Mice.

Published in:

Journal of Neuroscience, 2006, v. 26, n. 8, p. 2358, doi. 10.1523/JNEUROSCI.3819-05.2006

By:

Wrabetz, Lawrence;
D'Antonio, Maurizio;
Pennuto, Maria;
Dati, Gabriele;
Tinelli, Elisa;
Fratta, Pietro;
Previtali, Stefano;
Imperiale, Daniele;
Zielasek, Jurgen;
Toyka, Klaus;
Avila, Robin L.;
Kirschner, Daniel A.;
Messing, Albee;
Feltri, M. Laura;
Quattrini, Angelo

Publication type:

Article

Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination.

Published in:

2014

By:

da Silva, Tiago Ferreira;
Eira, Jessica;
Lopes, André T;
Malheiro, Ana R;
Sousa, Vera;
Luoma, Adrienne;
Avila, Robin L;
Wanders, Ronald J A;
Just, Wilhelm W;
Kirschner, Daniel A;
Sousa, Mónica M;
Brites, Pedro

Publication type:

journal article

Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination.

Published in:

Journal of Clinical Investigation, 2014, v. 124, n. 6, p. 2560, doi. 10.1172/JCI72063

By:

da Silva, Tiago Ferreira;
Eira, Jessica;
Lopes, André T.;
Malheiro, Ana R.;
Sousa, Vera;
Luoma, Adrienne;
Avila, Robin L.;
Wanders, Ronald J. A.;
Just, Wilhelm W.;
Kirschner, Daniel A.;
Sousa, Mónica M.;
Brites, Pedro

Publication type:

Article

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab.

Published in:

Drugs - Real World Outcomes, 2025, v. 12, n. 2, p. 301, doi. 10.1007/s40801-025-00495-w

By:

Blitz-Shabbir, Karen;
Banks, Aimee M.;
Garg, Hina;
Nelson, Flavia;
Shah, Suma;
Belviso, Nicholas;
Mendoza, Jason P.;
Avila, Robin L.;
Bian, Boyang;
Fong, Kinyee

Publication type:

Article

Lack of Collagen XV Impairs Peripheral Nerve Maturation and, When Combined with Laminin-41 1 Deficiency, Leads to Basement Membrane Abnormalities and Sensorimotor Dysfunction.

Published in:

Journal of Neuroscience, 2010, v. 30, n. 43, p. 14490, doi. 10.1523/JNEUROSCI.2644-10.2010

By:

Rasi, Karolina;
Hurskainen, Merja;
Kallio, Mika;
Stavén, Saara;
Sormunen, Raija;
Heape, Anthony M.;
Avila, Robin L.;
Kirschner, Daniel;
Muona, Anu;
Tolonen, Uolevi;
Tanila, Heikki;
Huhtala, Pirkko;
Soininen, Raija;
Pihiajaniemi, Taina

Publication type:

Article

(DXT12) Real-World Effectiveness of Peginterferon Beta-1a Versus Teriflunomide in US Multiple Sclerosis Patients.

Published in:

International Journal of MS Care, 2020, v. 22, n. S2, p. 20

By:

Roman, Cortnee;
Geremakis, Caroline;
Mendoza, Jason P.;
Su, Ray;
Makin, Charles;
Vignos, Megan C.;
Avila, Robin L.

Publication type:

Article

(DXT06) Real-World Effectiveness of Peginterferon Beta-1a Versus Interferon Beta-1a and Glatiramer Acetate in US Multiple Sclerosis Patients.

Published in:

International Journal of MS Care, 2020, v. 22, n. S2, p. 17

By:

Reder, Anthony T.;
Arndt, Nancy;
Geremakis, Caroline;
Mendoza, Jason P.;
Su, Ray;
Makin, Charles;
Vignos, Megan C.;
Avila, Robin L.

Publication type:

Article

The impact of social distancing measures on anti–JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 888, doi. 10.1177/13524585241232274

By:

Krieger, Stephen C;
Sinks, Susie;
Huang, Furong;
Steverson, Julie;
Kalina, Tamar J;
White, Kurt;
Avila, Robin L

Publication type:

Article

Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 687, doi. 10.1177/13524585241235055

By:

Nakamura, Kunio;
Sun, Zhaonan;
Hara-Cleaver, Claire;
Bodhinathan, Karthik;
Avila, Robin L

Publication type:

Article

Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study

Published in:

CNS Drugs, 2023, v. 37, n. 3, p. 275, doi. 10.1007/s40263-022-00982-6

By:

Perumal, Jai;
Balabanov, Roumen;
Su, Ray;
Chang, Roger;
Balcer, Laura J.;
Galetta, Steven L.;
Avila, Robin L.;
Rutledge, Danette;
Fox, Robert J.

Publication type:

Article

Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.

Published in:

2022

By:

Perumal, Jai;
Balabanov, Roumen;
Su, Ray;
Chang, Roger;
Balcer, Laura J.;
Galetta, Steven L.;
Avila, Robin L.;
Rutledge, Danette;
Fox, Robert J.

Publication type:

journal article

Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis.

Published in:

Journal of Negative Results in Biomedicine, 2007, v. 6, p. 8, doi. 10.1186/1477-5751-6-8

By:

McNally, Melanie A.;
Baek, Rena C.;
Avila, Robin L.;
Seyfried, Thomas N.;
Strichartz, Gary R.;
Kirschner, Daniel A.

Publication type:

Article

Evaluating natalizumab first-line and later-line use in multiple sclerosis: a US claims database analysis.

Published in:

Therapeutic Advances in Neurological Disorders, 2025, p. 1, doi. 10.1177/17562864251317949

By:

Avila, Robin L.;
Croteau, Nicole S.;
Tang, Fei;
Simeone, Jason C.;
Jomaa, Khalil;
Bian, Boyang;
Gianinazzi, Mattia

Publication type:

Article

A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination.

Published in:

Brain: A Journal of Neurology, 2010, v. 133, n. 10, p. 3017, doi. 10.1093/brain/awq247

By:

Traka, Maria;
Arasi, Kavin;
Avila, Robin L.;
Podojil, Joseph R.;
Christakos, Athena;
Miller, Stephen D.;
Soliven, Betty;
Popko, Brian

Publication type:

Article

Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis.

Published in:

Neurology & Therapy, 2023, v. 12, n. 3, p. 833, doi. 10.1007/s40120-023-00461-0

By:

Perumal, Jai;
Balabanov, Roumen;
Balcer, Laura;
Galetta, Steven;
Sun, Zhaonan;
Li, Hanyue;
Rutledge, Danette;
Avila, Robin L.;
Fox, Robert J.

Publication type:

Article

COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy.

Published in:

Neurology & Therapy, 2023, v. 12, n. 2, p. 687, doi. 10.1007/s40120-023-00448-x

By:

Jaber, Aliya;
Patel, Meera;
Sylvester, Andrew;
Yarussi, Mary;
Kalina, J. Tamar;
Mendoza, Jason P.;
Avila, Robin L.;
Tremblay, Matthew A.

Publication type:

Article